In this review, we provide a comprehensive overview of the underlying mechanisms of -cell failure in DM, highlight the effective approaches for -cell neogenesis, as well as discuss the current clinical and preclinical agents research advances of -cell neogenesis.
We highlight the current strategies of -cell neogenesis, including stimulation of -cell proliferation, inhibition of -cell dedifferentiation, promoting the differentiation of stem cells into islet -cells, and trans-differentiation of non--cells in the endocrine and exocrine pancreas.
Such details provide a deeper understanding and appreciation for Beta Cell Neogenesis From A Non.
Although the major mechanism of the maintenance of -cell mass after birth is thought to be self-replication of pre-existing -cells, it is possible that pancreatic -cells are also generated from non--cells. Here, we address this issue by using the inducible Cre/loxP system to trace -cells.
Where do new beta cells come from in adult organisms? Do they proliferate from existing beta cells, differentiate from progenitor cells, or transdifferentiate from non-beta cells into beta (-like) cells?
It has been suggested that new beta cells can arise from specific populations of adult pancreatic progenitors or facultative stem cells. However, their existence remains controversial, and the... Several researches have demonstrated the successful restoration of enhanced insulin secretion in diabetes induced mice. Additionally ductal neurogenin3 (Ngn3), Sglt2 inhibitors, Igfbp1, GLP1 and several clinical and non-clinical agents has been postulated as a basis of beta cell neogenesis. lthough the major mechanism of the maintenance of -cell mass after birth is thought to be selfreplication of pre-existing -cells, it is possible that pancreatic -cells are also...
lthough the major mechanism of the maintenance of -cell mass after birth is thought to be selfreplication of pre-existing -cells, it is possible that pancreatic -cells are also...
